23 July 1999
Operating from 76 different countries, the company’s extensive drug portfolio includes the ulcer blockbuster Zantac and the asthma inhaler Ventolin. Glaxo Wellcome is about to launch two new products: Ziagen, a new anti-HIV treatment, and its latest asthma drug, Flixotide.
You must be logged in to continue
Register for free to finish this article
Registration includes the following benefits:
To access this article REGISTER NOW
Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.